Last reviewed · How we verify
NCT06358443: PF-JB3
The Long-term Effect of Daily Jarlsberg Cheese Intake in Patient With Osteopenia
NA trial testing Jarlsberg cheese in Osteopenia in 20 participants. Completed in 4 November 2024.
18 October 2024
Quick facts
| Lead sponsor | Meddoc |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 20 |
| Start date | 3 June 2024 |
| Primary completion | 18 October 2024 |
| Estimated completion | 4 November 2024 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Jarlsberg cheese
Conditions studied
- Osteopenia — all drugs for Osteopenia →
- Osteoporosis — all drugs for Osteoporosis →
Sponsor
Meddoc — full company profile →
Who can join
Under 80, any sex, with Osteopenia or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aim: To estimate the effect of daily optimal efficacy dose (OED) of Jarlsberg cheese in patients with Osteopeni (OP). Study population: Post-menopausal women and men above 55 years of age in risk of Osteoporosis Treatment: Daily OED Jarlsberg cheese + vitamin D and Calcium tablets. Design: An open and one-armed observational study. Main variables: Bone Mineral Density (BMD), Bone turnover markers (BTMs), Osteocalcin and K2 vitameres. Study Procedure: Prior to inclusion in this study, all the patients have undergone 32 days of daily OED intake of Jarlsberg cheese + vitamin D and caicium tablets. Thid is the baseline of this observational study. The duration of this study is 12 months with clinical examination and bloodsampling after 6 and 12 months. Sample size: At least 16 patients will be included
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06358443
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Jarlsberg cheese
Trials testing the same drug.
- NCT06688032 — Efficacy Comparison of Jarlsberg- and Norvegia Cheese on Bone Markers and Bone Mineral Density in Nordic Skiers · NA · completed
- NCT05434806 — Daily Dose Estimation of Jarlsberg Cheese in Healthy Norwegian Elderly Male and Female · NA · completed
- NCT05447936 — Dose Estimation of Jarlsberg Cheese in Young, Active Norwegian Cross-country Skiers (XCS) · NA · completed
- NCT04185454 — Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese · NA · completed
Other recruiting trials for Osteopenia
Currently open trials in the same condition.
- NCT07473713 — Veverimer to Decrease Net Acid Excretion and Bone Resorption in Adults With Osteopenia · Phase 1 · recruiting
- NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
- NCT07412782 — REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) · NA · recruiting
- NCT07187518 — Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound Device · NA · recruiting
- NCT07191353 — Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women · Phase 2 · recruiting
Other Meddoc trials
Trials by the same sponsor.
- NCT06973694 — Validation of Bulbicam Used on Patient Suffering From Diabetes Without Retinopathy · completed
- NCT05787808 — Profylactic Treatment for Patients in Risk Osteoporosis · NA · recruiting
- NCT06688032 — Efficacy Comparison of Jarlsberg- and Norvegia Cheese on Bone Markers and Bone Mineral Density in Nordic Skiers · NA · completed
- NCT04186585 — Recommended Dose Estimation of BP-C2 · Phase 1 · recruiting
- NCT05434806 — Daily Dose Estimation of Jarlsberg Cheese in Healthy Norwegian Elderly Male and Female · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06358443 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Meddoc
- Last refreshed: 9 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06358443.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing